Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards $9.8M to 17 Early-Detection Biomarker-Development Labs

NEW YORK, Nov. 22 (GenomeWeb News) - The National Cancer Institute has awarded $9.8 million to 17 Biomarkers Developmental Laboratories within the Early Detection Research Network, the agency announced last week.


Institutions that were granted the first-year funding include the Universityof Pittsburgh, FoxChaseCancerCenter, the Universityof Michigan, M.D.AndersonCancerCenter, FredHutchinsonCancerResearchCenterand JohnsHopkinsUniversity. A complete list of grantees is available here.


Investigators at the BDL will examine the human genome, proteome, epitome, and metabolome to identify biomarkers that can potentially serve as early detection biomarkers and markers of progression of the disease.


"The synergized power of DNA arrays, protein arrays and bioinformatics are being used to help decipher hundreds of thousands of leads to discover unique signatures for early cancer," said Sudhir Srivastava, the chief of the cancer biomarker research group at NCI's Division of Cancer Prevention.


The NCI received 68 applications to serve as Biomarker Developmental Laboratories, out of which 17 were selected for funding. The funding is the second round of five-year funding for components of the EDRN.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.